STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma

Conditions: Liver Cancer

First Posted Date: 2010-02-26

Last Posted Date: 2021-04-01

Lead Sponsor: Stanford University

Registration Number: NCT01076517

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors

Terminated

Conditions: Pancreatic Cancer
Lung Cancer Non-Small Cell Cancer (NSCLC)
Hepatobiliary Cancers
Liver Cancer
Lung Cancer
Hepatobiliary Cancers Gallbladder
Hepatobiliary Cancers Liver
Hepatobiliary Cancers Bile Duct
Lung Cancer Small Cell Lung Cancer (SCLC)
Hepatobiliary Cancers Hepatocellular Carcinoma (Hepatoma)

First Posted Date: 2010-02-19

Last Posted Date: 2012-12-07

Lead Sponsor: Stanford University

Target Recruit Count: 5

Registration Number: NCT01071434

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

A Randomized Control Trial Comparing Linjeta Versus Humalog in Pumps: Effect on Postprandial Blood Sugars.

Phase 2

Withdrawn

Conditions: Diabetes Mellitus

Interventions: Drug: Humalog U-100
Drug: LINjeta U-100 Insulin

First Posted Date: 2010-02-11

Last Posted Date: 2017-02-10

Lead Sponsor: Stanford University

Registration Number: NCT01067118

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
🇺🇸
University of Colorado Denver School of Medicine Barbara Davis Center, Denver, Colorado, United States

Stanford Accelerated Recovery Trial (START)

Phase 3

Terminated

Conditions: Pain
Breast Cancer
Lung Cancer

Interventions: Drug: Lorazepam (active control)
Drug: Gabapentin
Drug: Placebo (inactive)

First Posted Date: 2010-02-11

Last Posted Date: 2022-05-05

Lead Sponsor: Stanford University

Target Recruit Count: 422

Registration Number: NCT01067144

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Imaging the Nucleus Accumbens in Major Depressed Patients 'Treated With Pramipexole

Phase 4

Terminated

Conditions: Depression

Interventions: Drug: Pramipexole

First Posted Date: 2010-02-10

Last Posted Date: 2017-05-16

Lead Sponsor: Stanford University

Target Recruit Count: 16

Registration Number: NCT01066897

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies

Withdrawn

Conditions: Skin Cancers
Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)
Bladder Cancer
Bladder (Urothelial, Transitional Cell) Cancer

First Posted Date: 2010-02-02

Last Posted Date: 2019-04-18

Lead Sponsor: Stanford University

Registration Number: NCT01060319

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma

Phase 2

Terminated

Conditions: Angiosarcomas
Soft Tissue Sarcoma

Interventions: Drug: Bevacizumab
Drug: Paclitaxel

First Posted Date: 2010-01-25

Last Posted Date: 2018-03-26

Lead Sponsor: Stanford University

Target Recruit Count: 18

Registration Number: NCT01055028

Locations: 🇺🇸
Santa Monica Sarcoma Center, Santa Monica, California, United States
🇺🇸
MD Anderson Sarcoma Center, Houston, Texas, United States
🇺🇸
Stanford University Medical Center, Stanford, California, United States

Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial.

Phase 1

Completed

Conditions: Pregnancy Complications

Interventions: Drug: 17-Hydroxyprogesterone Caproate
Other: Caster Oil injections

First Posted Date: 2010-01-15

Last Posted Date: 2019-04-09

Lead Sponsor: Stanford University

Target Recruit Count: 21

Registration Number: NCT01050647

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
🇺🇸
Santa Clara Valley Medical Center, San Jose, California, United States

Genomic Analysis of Pediatric Bone Tumors

Completed

Conditions: Bone Cancer

First Posted Date: 2010-01-13

Last Posted Date: 2020-07-28

Lead Sponsor: Stanford University

Target Recruit Count: 163

Registration Number: NCT01047878

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Healthier Living Canada

Phase 2

Completed

Conditions: Asthma
Chronic Disease

Interventions: Behavioral: Chronic Disease Self-Management Online Workshop

First Posted Date: 2010-01-13

Last Posted Date: 2014-09-17

Lead Sponsor: Stanford University

Target Recruit Count: 297

Registration Number: NCT01047514

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy